Skip to Main Content
877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
877-YALEMDS
ALL KEYWORDS

Chronic Myelomonocytic Leukemia (CMML)

Related Specialists

Showing 3 of 12
  • Stuart Seropian

    MD
  • Alexa Siddon

    MD
  • Amer Zeidan

    MBBS, MD
More Related Specialists

Related Fact Sheets

  • Chronic Myeloid Leukemia (CML)

  • Diagnosing Leukemia

Related Clinical Trials

Showing 2 of 5
  • MYELOMATCH: A Screening Study to Assign People with Myeloid Cancer to a Treatment Study or Standard of Care Treatment within myeloMATCH (MyeloMATCH Screening Trial)

    • Leukemia & Hematologic Cancers
    • A Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)

      • Leukemia & Hematologic Cancers
      More Related Clinical Trials

      Related Departments

      Showing 3 of 23
      • Radiology & Biomedical Imaging

      • Pediatrics

      • Leukemia & Lymphoma Program

      More Related Departments
      • About Us
      • Contact Us
      • Donate
      • Referring Doctors
      • Clinical Keywords

      333 Cedar St.

      New Haven, CT 06510

      • Yale School of Medicine
      • Yale University
      • Terms & Privacy Policies
      • Accessibility at YSM
      • Patient Rights
      • HIPAA at Yale
      • Non-discrimination Statement
      Copyright 2026 Yale Medicine